Major causes of death among men and women in China.

BACKGROUND With China's rapid economic development, the disease burden may have changed in the country. We studied the major causes of death and modifiable risk factors in a nationally representative cohort of 169,871 men and women 40 years of age and older in China. METHODS Baseline data on the participants' demographic characteristics, medical history, lifestyle-related risk factors, blood pressure, and body weight were obtained in 1991 with the use of a standard protocol. The follow-up evaluation was conducted in 1999 and 2000, with a follow-up rate of 93.4 percent. RESULTS We documented 20,033 deaths in 1,239,191 person-years of follow-up. The mortality from all causes was 1480.1 per 100,000 person-years among men and 1190.2 per 100,000 person-years among women. The five leading causes of death were malignant neoplasms (mortality, 374.1 per 100,000 person-years), diseases of the heart (319.1), cerebrovascular disease (310.5), accidents (54.0), and infectious diseases (50.5) among men and diseases of the heart (268.5), cerebrovascular disease (242.3), malignant neoplasms (214.1), pneumonia and influenza (45.9), and infectious diseases (35.3) among women. The multivariate-adjusted relative risk of death and the population attributable risk for preventable risk factors were as follows: hypertension, 1.48 (95 percent confidence interval, 1.44 to 1.53) and 11.7 percent, respectively; cigarette smoking, 1.23 (95 percent confidence interval, 1.18 to 1.27) and 7.9 percent; physical inactivity, 1.20 (95 percent confidence interval, 1.16 to 1.24) and 6.8 percent; and underweight (body-mass index [the weight in kilograms divided by the square of the height in meters] below 18.5), 1.47 (95 percent confidence interval, 1.42 to 1.53) and 5.2 percent. CONCLUSIONS Vascular disease and cancer have become the leading causes of death among Chinese adults. Our findings suggest that control of hypertension, smoking cessation, increased physical activity, and improved nutrition should be important strategies for reducing the burden of premature death among adults in China.

[1]  Jing Chen,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension in China , 2002, Hypertension.

[2]  K. Reynolds,et al.  Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China , 2004, Circulation.

[3]  R. Peto,et al.  Emerging tobacco hazards in China , 1999, BMJ.

[4]  R. Peto,et al.  Emerging tobacco hazards in China: 2. Early mortality results from a prospective study , 1998, BMJ.

[5]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[6]  K. Reynolds,et al.  Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. , 2004, American journal of public health.

[7]  E. Freis,et al.  Recommendations for Human Blood Pressure Determination By Sphygmomanometers: CONTENTS , 1981, Circulation.

[8]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[9]  B. Henderson,et al.  Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. , 1996, JAMA.

[10]  P. Heuveline,et al.  The burden of disease among the global poor , 1999, The Lancet.

[11]  A. C. Burton,et al.  RECOMMENDATIONS for human blood pressure determinations by sphygmomanometers. , 1967, Journal of the American Medical Association.

[12]  T. Lam,et al.  Mortality attributable to cigarette smoking in China. , 1997, JAMA.

[13]  R. Collins,et al.  Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. , 1997, JAMA.

[14]  K. Kochanek,et al.  Deaths: preliminary data for 2002. , 2004, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[15]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[16]  R. Peto,et al.  Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths , 1998, BMJ.

[17]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[18]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[19]  D. Yach,et al.  The global burden of chronic diseases: overcoming impediments to prevention and control. , 2004, JAMA.

[20]  Octavio Gómez Dantés,et al.  The World Health Report 1999. Making a Difference , 1999 .

[21]  X. Duan,et al.  Prevalence of hypertension and its trends in Chinese populations. , 1995, International journal of cardiology.

[22]  M. Feinleib National Center for Health Statistics (NCHS) , 2005 .

[23]  G. Kvåle Global health status: two steps forward, one step back , 2000, The Lancet.

[24]  Xi-gui Wu,et al.  A north‐south comparison of blood pressure and factors related to blood pressure in the People's Republic of China: a report from the PRC‐USA Collaborative Study of Cardiovascular Epidemiology , 1994, Journal of hypertension.

[25]  H. A. Kahn,et al.  Statistical Methods in Epidemiology , 1989 .